Document is current
Any future updates will be listed below
-
Authors
Brenneman, Douglas E.
Petkanas, Dean
Ippolito, Michael
Ward, Sara Jane
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R42NS120548)
National Institute of Neurological Disorders and Stroke (R42NS120548)
National Institute of Neurological Disorders and Stroke (R42NS120548)
National Institute of Neurological Disorders and Stroke (R42NS120548)
- License Information
-
More Information
Article History
Received: 31 December 2024
Accepted: 20 February 2025
First Online: 14 March 2025
Declarations
:
: This research did not involve animal or human subjects.
: Dr. Brenneman is a patent holder of KLS-13019, an antagonist to the GPR55 receptor which is mentioned in this paper. Dr. Brenneman in on the editorial board of the Journal of Molecular Neuroscience.
